Ad is loading...
OSTVX
Price
$17.53
Change
-$0.19 (-1.07%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

OSTVX vs RAMHX

Header iconOSTVX vs RAMHX Comparison
Open Charts OSTVX vs RAMHXBanner chart's image
Osterweis Growth & Income Fund
Price$17.53
Change-$0.19 (-1.07%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
OSTVX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OSTVX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSTVX is a Buy and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. OSTVX (186M). OSTVX pays higher dividends than RAMHX: OSTVX (2.53) vs RAMHX (1.84). OSTVX was incepted earlier than RAMHX: OSTVX (14 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. OSTVX (33.00). RAMHX has a lower initial minimum investment than OSTVX: RAMHX (250) vs OSTVX (5000). RAMHX annual gain was more profitable for investors over the last year : 20.31 vs. OSTVX (14.33). RAMHX return over 5 years is better than : 32.43 vs. OSTVX (26.93).
OSTVXRAMHXOSTVX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years10 years-
Gain YTD10.18913.58275%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets186M236B0%
Annual Yield % from dividends2.531.84137%
Returns for 1 year14.3320.3171%
Returns for 3 years-5.539.39-59%
Returns for 5 years26.9332.4383%
Returns for 10 years40.8746.7487%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings